228 related articles for article (PubMed ID: 17894071)
1. Photic responses in "minimal brain dysfunction".
Milstein V; Small JG
Dis Nerv Syst; 1974 Aug; 35(8):355-7. PubMed ID: 17894071
[No Abstract] [Full Text] [Related]
2. Pemoline in ADHD.
Winsberg B; Barbato M
J Am Acad Child Adolesc Psychiatry; 1997 Dec; 36(12):1649-50. PubMed ID: 9401321
[No Abstract] [Full Text] [Related]
3. Compliance with FDA recommendations for pemoline.
Sarkis EH
J Am Acad Child Adolesc Psychiatry; 2003 Apr; 42(4):383; author reply 383. PubMed ID: 12649623
[No Abstract] [Full Text] [Related]
4. Medication for attention deficit hyperactivity disorder: commentary and response.
Faigel HC; Heiligenstein E
J Am Coll Health; 1996 Jul; 45(1):40-1; discussion 41-2. PubMed ID: 8708265
[No Abstract] [Full Text] [Related]
5. Pemoline (Cylert): market withdrawal.
Hogan V
CMAJ; 2000 Jan; 162(1):106, 110. PubMed ID: 11216184
[No Abstract] [Full Text] [Related]
6. The neurology of attention deficit/hyperactivity disorder.
Curatolo P
Brain Dev; 2005 Dec; 27(8):541-3. PubMed ID: 16310587
[No Abstract] [Full Text] [Related]
7. Coming into focus. Pharmacologic treatment for ADHD.
McDonnell MA; Moffett C
Adv NPs PAs; 2010 Dec; 1(4):16-22; quiz 23. PubMed ID: 21319448
[No Abstract] [Full Text] [Related]
8. Pharmacological treatment of attention deficit disorder, residual type (ADD,RT, "minimal brain dysfunction," "hyperactivity") in adults.
Wender PH; Wood DR; Reimherr FW
Psychopharmacol Bull; 1985; 21(2):222-31. PubMed ID: 3923527
[No Abstract] [Full Text] [Related]
9. Misinterpreting emotional expressions in attention-deficit/hyperactivity disorder: evidence for a neural marker and stimulant effects.
Williams LM; Hermens DF; Palmer D; Kohn M; Clarke S; Keage H; Clark CR; Gordon E
Biol Psychiatry; 2008 May; 63(10):917-26. PubMed ID: 18272140
[TBL] [Abstract][Full Text] [Related]
10. Pemoline (Cylert) for minimal brain dysfunction.
Med Lett Drugs Ther; 1976 Jan; 18(2):5-6. PubMed ID: 1107790
[No Abstract] [Full Text] [Related]
11. [Emotional regulation and motivation in children with ADHD].
Høvik MF; Plessen KJ
Tidsskr Nor Laegeforen; 2010 Dec; 130(23):2349-52. PubMed ID: 21139659
[TBL] [Abstract][Full Text] [Related]
12. Attention deficit hyperactivity in adults.
Cubbin S; Leahy A
Br J Psychiatry; 1998 Apr; 172():366. PubMed ID: 9715347
[No Abstract] [Full Text] [Related]
13. Attention-deficit hyperactivity disorder and anesthesia.
Forsyth I; Bergesio R; Chambers NA
Paediatr Anaesth; 2006 Apr; 16(4):371-3. PubMed ID: 16618289
[No Abstract] [Full Text] [Related]
14. Attention-deficit/hyperactivity disorder: advances in diagnostic and therapeutic approaches.
DelBello MP
J Clin Psychiatry; 2008 Jan; 69(1):130. PubMed ID: 18312047
[No Abstract] [Full Text] [Related]
15. Mechanism of action of stimulants in attention-deficit/hyperactivity disorder.
Stahl SM
J Clin Psychiatry; 2010 Jan; 71(1):12-3. PubMed ID: 20129003
[No Abstract] [Full Text] [Related]
16. Event-related wave activity in the EEG provides new marker of ADHD.
Alexander DM; Hermens DF; Keage HA; Clark CR; Williams LM; Kohn MR; Clarke SD; Lamb C; Gordon E
Clin Neurophysiol; 2008 Jan; 119(1):163-79. PubMed ID: 18054279
[TBL] [Abstract][Full Text] [Related]
17. Abnormal auditory P300 topography in attention deficit disorder predicts poor response to pemoline.
Sangal JM; Sangal RB; Persky B
Clin Electroencephalogr; 1995 Oct; 26(4):204-13. PubMed ID: 8575100
[TBL] [Abstract][Full Text] [Related]
18. Are psychostimulants a treatment option in mania?
Hegerl U; Sander C; Olbrich S; Schoenknecht P
Pharmacopsychiatry; 2009 Sep; 42(5):169-74. PubMed ID: 19724978
[TBL] [Abstract][Full Text] [Related]
19. Stimulants, ADHD, and the heart.
Ganiats TG
Am Fam Physician; 2009 May; 79(10):846, 851. PubMed ID: 19496384
[No Abstract] [Full Text] [Related]
20. Adult ADHD research: current status and future directions.
Ramsay JR; Rostain AL
J Atten Disord; 2008 May; 11(6):624-7. PubMed ID: 18417728
[No Abstract] [Full Text] [Related]
[Next] [New Search]
